GNTA Stock Analysis: Buy, Sell, or Hold?
GNTA - Genenta Science S.p.A. American Depositary Shares
$0.63
-0.01 (-1.16%)
▼
5d:
-13.32%
30d:
-6.8%
90d:
-13.55%
WAIT
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: Mar 27, 2026
0d
Get Alerted When GNTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GNTA is down 13.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GNTA is down 13.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GNTA is currently trading at $0.63, which is considered oversold relative to its 30-day fair value range of $0.66 to $0.72.
Technical Outlook: Technically, GNTA is in a strong downtrend. The price is currently testing key support at $0.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.98 (+990.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GNTA is in a strong downtrend. The price is currently testing key support at $0.62. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.98 (+990.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.66 -
$0.72
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 990.3% below Wall St target ($6.98)
- WARNING: Recommendation downgraded due to -13.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.66 -
$0.72
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.62
Resistance Level
$0.77
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.21
Wall Street Target
$6.98
(+990.3%)
Share & Embed Analysis
Last updated: May 08, 2026 1:07 PM ET
Data refreshes hourly during market hours. Next update: 2:07 PM
Data refreshes hourly during market hours. Next update: 2:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$100 | 69 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$93 | 67 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 55 HOLD |
